Liminal BioSciences Inc.
LMNL · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $37 | $108 | $45 | $61 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $4 | $13 |
| Inventory | $0 | $0 | $9 | $8 |
| Other Curr. Assets | $3 | $5 | $15 | $13 |
| Total Curr. Assets | $41 | $115 | $73 | $95 |
| Property Plant & Equip (Net) | $5 | $7 | $27 | $55 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3 | $4 | $15 | $14 |
| Long-Term Investments | $0 | $0 | $0 | $1 |
| Tax Assets | $0 | $0 | $1 | $1 |
| Other NC Assets | $0 | $0 | $1 | $0 |
| Total NC Assets | $9 | $11 | $45 | $70 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $50 | $126 | $118 | $165 |
| Liabilities | – | – | – | – |
| Payables | $3 | $6 | $9 | $10 |
| Short-Term Debt | $1 | $7 | $7 | $8 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $5 | $8 | $12 |
| Total Curr. Liab. | $10 | $18 | $24 | $31 |
| LT Debt | $1 | $54 | $67 | $39 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $20 | $12 | $0 |
| Total NC Liab. | $4 | $74 | $79 | $39 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $14 | $92 | $103 | $70 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $980 | $980 | $977 | $933 |
| Retained Earnings | -$1,082 | -$1,074 | -$1,087 | -$967 |
| AOCI | -$3 | -$3 | -$3 | -$3 |
| Other Equity | $142 | $140 | $136 | $139 |
| Total Equity | $36 | $43 | $23 | $102 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | -$9 | -$8 | -$7 |
| Total Liab. & Tot. Equity | $50 | $126 | $118 | $165 |
| Net Debt | -$36 | -$48 | $29 | -$14 |